Plan for the use and dissemination of foreground Sample Clauses

Plan for the use and dissemination of foreground. Dissemination is a central part of MOLTO, not the least because we see the project itself as a starting phase of something that has the potential of growing to much larger dimensions: to cover hundreds of languages, thousands of applications, and millions of users. Early in the project we will start by delivering a Web site uniting research, industry and user facing information about MOLTO’s technology and potential. There we will feature our pre- existing work with light-weight demos, regularly updated as our work progresses, and ultimately including the use case systems. Some of these demos will be easy to integrate in third party applications like Wikis or social networks, to face larger audiences. The web site will also include a vibrant blog section with frequent informal posts on internal progress and plans and encouraging community contributions. Dissemination on conferences, symposiums and workshops will be in the areas of language technology and translation, semantic technologies, and information retrieval and will include papers, posters, exhibition booths and sponsorships (by Ontotext at web and semantic technology conferences like ISWC, WWW, SemTech), and academic/professional events such as the Information Retrieval Facility Symposium. We will also organize a set of MOLTO workshops for the expert audience, featuring invited speakers and potential users from academy and industry. Ontotext will make the multi-lingual NL retrieval and presentation interfaces to structured knowledge as a standard feature in their semantic search products. A major target group for dissemination is Patent Searchers/Researchers. The ability to do inline translation of segments of patents will enhance their productivity. Moreover, Ontotext, in cooperation with EPO, will endeavour to disseminate the results of the MOLTO project at academic, industrial or semi- industrial events such as, for instance, the Information Retrieval Facility Symposium, an event which brings together scientists in the field of information retrieval and intellectual property searchers/researchers, as well as the PAIR workshop. Due to the evolving nature of the industry actual appropriate events will be decided during the course of the project Dissemination through related networks. MOLTO dissemination efforts will benefit from close cooperation with expected activities of T4ME (Technologies for the Multilingual European Information Society) Network of Excellence. T4ME language resource infrastr...
Sample 1
AutoNDA by SimpleDocs
Plan for the use and dissemination of foreground. The results and standards generated by BBMRI will be disseminated in public meetings, most importantly the stakeholder meeting, through various public reports and a dedicated website. One of the central aims of BBMRI is the dissemination of its work, to reach stakeholders, scientific community and general public as widely as possible. This work is shared between all workpackages, with central roles of WP1, WP6 and WP7. BBMRI will in this role contribute to policies, and harmonize standards, with emphasis on international standardization. This role will be achieved by cooperation with various international standardization organizations (P3G, IMI, OECD, WHO), in which WP1 plays a specific role. The assessment of risks is integrated in the ‘operative’ workpackages (WP2, WP3, WP4 and WP5) and will be monitored by WP6 with respect to XXXX. Public relations and dissemination are also major tasks of the executive management and will be addressed in addition to organizing an international conference in the context of the public consultation process at the beginning of year two. This will be done by establishing and hosting a web-site, preparation of flyers and brochures (for professionals and the general public) as well as press releases. For the various documents, input will be received from the respective work package leaders with special emphasis on scientific as well as on ethical and societal issues. The design of information materials and the hosting of the web-site will be outsourced. For further details see description of WP1. The goal of the ‘operative’ workpackages WP2 – WP6 is to integrate and harmonize existing standards and if required to generate new standards in their respective fields on a European level (see workpackage descriptions). Within WP1, this harmonisation is taken to the international level by involving previous efforts within international consortia, such as the WHO, OECD and P3G. ▪ BBMRI will have a catalytic effect in this respect because standardisation will reduce the organisational and financial barriers for the design and implementation of experimental research projects using BBMRI’s resources across the biomedical sciences. ▪ the scientifically justified further development of infrastructure (especially in the outermost regions of the EU). ▪ BBMRI will have an optimising effect because, in order to function, it is essential that it implements agreed standards for biological resources and data so as to enable distribution. BBMRI w...
Sample 1
Plan for the use and dissemination of foreground. The knowledge of the Partners and information gathered and experiences gained during the BalticGrid project will be used to support performing dissemination and outreach tasks in BalticGrid-II project.
Sample 1
Plan for the use and dissemination of foreground. A dissemination plan will be prepared and implemented along the project and beyond. The plan will permit: to establish target audiences and define key messages, to select the appropriate modes and tools of communication, to implement the dissemination activities among partners. It will be mainly targeted to the construction and construction supplier (equipment, components, ICT) industries stakeholders and to the ICT industry but also to citizens for fulfilling the societal objectives of spreading education and generating enthusiasm for energy efficiency and emission reduction. In relation to dissemination activities, a dedicated website will be developed, at the beginning of the project, and maintained. This website will enable the publication and updating of the new advances to a wider audience. This site will be linked to all relevant organizations and maintained after the conclusion of the project, for being interactive and accessible by professionals and researchers. In addition the web-seminar will be organized for experts and for the public in particular for research directed journalists and video clips will be produced and published on the ISES website and on public websites like Youtube, too. Dissemination to the industry will be done through the newsletters, web portals and the presence of the industrial partners and the research institutes at trade shows. ISES aims at becoming visible in the global construction community by presenting itself on the ETCP. In addition the academic and research partners will publish scientific papers and participate in conference in the (1) energy and emission efficient buildings, (2) building and facility component developers, (3) BIM/model-based design, (4) distributed, collaborative systems and concurrent engineering, (5) ontologies and virtual enterprises. They will use their position in the editorial boards of conferences and journals (TUD, UL) to promote the idea of integrated collaborative energy and emission simulation tools and interoperability of STEP-BIM-BAS and organise special issues and sessions. Open access media will be preferred, because they allow faster and wider dissemination. The academic partners will also build the findings into their graduate and postgraduate curricula. A dissemination manager acting as assistant for the project manager will be installed in order to coordinate on a daily basis the dissemination activities. This position is given to SOF, which has long time experience in this ...
Sample 1
Plan for the use and dissemination of foreground. The second version of the IPR Directory (D7.5.2) will include detailed plan on the IP and Access Rights regarding the final version of the Miraculous-Life Solution, determining the rules partners shall follow for exploitation and dissemination of the projects outcomes and results, according to their intentions.
Sample 1
Plan for the use and dissemination of foreground. The final report resulting from this DS will be delivered to the appropriate funding agencies and policy makers (ApPEC, ASPERA, national agencies) for their evaluation. After appropriate reviews and consultancy, the respective organisations are expected to make decisions to define possible further steps to realise the considered infrastructure. In particular, we think that the report could be relevant to initiate its
Sample 1
Plan for the use and dissemination of foreground. SHARE will ensure the distribution and exploitation of results at all levels. Dissemination mechanisms have been built in the project structure, a dedicated portal will be built and a full work package (WP7) is introduced with the declared goal of enabling dissemination and exploitation of databases, results and tools developed by SHARE.
Sample 1
AutoNDA by SimpleDocs
Plan for the use and dissemination of foreground 
Sample 1Sample 2

Related to Plan for the use and dissemination of foreground

  • Specific Use and Disclosure Provisions (A) Except as otherwise limited in this Section of the Contract, Business Associate may use PHI for the proper management and administration of Business Associate or to carry out the legal responsibilities of Business Associate. (B) Except as otherwise limited in this Section of the Contract, Business Associate may disclose PHI for the proper management and administration of Business Associate, provided that disclosures are Required by Law, or Business Associate obtains reasonable assurances from the person to whom the information is disclosed that it will remain confidential and used or further disclosed only as Required by Law or for the purpose for which it was disclosed to the person, and the person notifies Business Associate of any instances of which it is aware in which the confidentiality of the information has been breached. (C) Except as otherwise limited in this Section of the Contract, Business Associate may use PHI to provide data aggregation services to Covered Entity as permitted by 45 C.F.R. § 164.504(e)(2)(i)(B).

  • General Use and Disclosure Provisions Except as otherwise limited in this Section of the Contract, Business Associate may use or disclose PHI to perform functions, activities, or services for, or on behalf of, Covered Entity as specified in this Contract, provided that such use or disclosure would not violate the HIPAA Standards if done by Covered Entity or the minimum necessary policies and procedures of the Covered Entity.

  • General Use and Disclosure Provisions Except as otherwise limited in this Section of the Contract, Business Associate may use or disclose PHI to perform functions, activities, or services for, or on behalf of, Covered Entity as specified in this Contract, provided that such use or disclosure would not violate the HIPAA Standards if done by Covered Entity or the minimum necessary policies and procedures of the Covered Entity.

  • Restrictions on Use and Disclosure Covered Entity shall notify Business Associate of any restriction on the use or disclosure of PHI that Covered Entity has agreed to in accordance with 45 C.F.R. § 164.522, to the extent such restriction may affect Business Associate’s use or disclosure of PHI.

  • Notification and Distribution of Materials The Company shall notify the Holders in writing of the effectiveness of the Resale Shelf Registration Statement as soon as practicable, and in any event within one (1) Business Day after the Resale Shelf Registration Statement becomes effective, and shall furnish to them, without charge, such number of copies of the Resale Shelf Registration Statement (including any amendments, supplements and exhibits), the Prospectus contained therein (including each preliminary prospectus and all related amendments and supplements) and any documents incorporated by reference in the Resale Shelf Registration Statement or such other documents as the Holders may reasonably request in order to facilitate the sale of the Registrable Securities in the manner described in the Resale Shelf Registration Statement.

  • Use and Disclosure All Confidential Information of a party will be held in confidence by the other party with at least the same degree of care as such party protects its own confidential or proprietary information of like kind and import, but not less than a reasonable degree of care. Neither party will disclose in any manner Confidential Information of the other party in any form to any person or entity without the other party’s prior consent. However, each party may disclose relevant aspects of the other party’s Confidential Information to its officers, affiliates, agents, subcontractors and employees to the extent reasonably necessary to perform its duties and obligations under this Agreement and such disclosure is not prohibited by applicable law. Without limiting the foregoing, each party will implement physical and other security measures and controls designed to protect (a) the security and confidentiality of Confidential Information; (b) against any threats or hazards to the security and integrity of Confidential Information; and (c) against any unauthorized access to or use of Confidential Information. To the extent that a party delegates any duties and responsibilities under this Agreement to an agent or other subcontractor, the party ensures that such agent and subcontractor are contractually bound to confidentiality terms consistent with the terms of this Section 11.

  • LIMITATIONS ON REVERSE ENGINEERING, DECOMPILATION AND DISASSEMBLY You may not reverse engineer, decompile, or disassemble the Software, except and only to the extent that such activity is expressly permitted by applicable law notwithstanding this limitation.

  • Permitted Use and Disclosures Each Party hereto may use or disclose Information disclosed to it by the other Party to the extent such use or disclosure: (i) is reasonably necessary in complying with Applicable Laws or otherwise submitting information to tax or other governmental authorities, (ii) is provided by the receiving Party to Third Parties, on a strictly as-needed basis, for consulting services, conducting Preclinical or Clinical Development, CMC/Process Development, Manufacturing, external testing, market research, or otherwise exercising its rights or performing its obligations hereunder; provided, that such Third Parties are obligated to maintain the confidentiality of such other Party’s Information as set forth herein for the benefit of such other Party for a period of at least the term of the agreement with such Third Party and for a period of *** thereafter; (iii) is included in submissions by the receiving Party to Governmental Authorities to facilitate the issuance of approvals for NDAs and NDA Equivalents for the Product, provided that reasonable measures shall be taken to assure confidential treatment of such Information; or (iv) is to Third Parties in connection with a receiving Party’s efforts to secure financing or enter into strategic partnerships, provided such Information is disclosed only on a need-to-know basis and under confidentiality provisions at least as stringent as those in this Agreement. Additionally, Bayer may disclose to Mitsui any Information received from Licensee hereunder; provided, that such disclosure is reasonably considered by Bayer to be necessary to comply with the terms and conditions of the Patent License Agreement; and further provided, that Mitsui is obligated to maintain the confidentiality of Licensee’s Information as set forth herein for the benefit of Licensee. Notwithstanding the foregoing, if a receiving Party is required to make any such disclosure of the disclosing Party’s confidential Information, other than pursuant to a confidentiality agreement, the receiving Party will give reasonable advance notice to the disclosing Party of such disclosure and, save to the extent inappropriate in the case of patent applications, will use its reasonable efforts to secure confidential treatment of such Information prior to its disclosure (whether through protective orders or otherwise).

  • Permitted Uses and Disclosures of Phi by Business Associate Except as otherwise indicated in this Agreement, Business Associate may use or disclose PHI, inclusive of de-identified data derived from such PHI, only to perform functions, activities or services specified in this Agreement on behalf of DHCS, provided that such use or disclosure would not violate HIPAA or other applicable laws if done by DHCS.

  • Incorporation of Software Code I agree that I will not incorporate into any Company software or otherwise deliver to Company any software code licensed under the GNU General Public License or Lesser General Public License or any other license that, by its terms, requires or conditions the use or distribution of such code on the disclosure, licensing, or distribution of any source code owned or licensed by Company except in strict compliance with Company’s policies regarding the use of such software.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!